Windtree Completes Enrollment of Phase 2 Study of Istaroxime in Early Cardiogenic Shock
On track for top-line data in April 2022 WARRINGTON, Pa., March 15, 2022 (GLOBE NEWSWIRE)…
News
Nabriva Therapeutics to Report 2021 Financial Results and Recent Corporate Highlights on March 29, 2022
DUBLIN, Ireland and FORT WASHINGTON, Pa., March 15, 2022 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc…
Entrada Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
On track to submit IND application for ENTR-601-44 targeting Duchenne muscular dystrophy in 2H 2022…
Imara Reports Full Year 2021 Financial Results and Business Highlights
Completed enrollment in Phase 2b sickle cell disease and beta-thalassemia trials with tovinontrine (IMR-687); expect…
Kane Biotech Announces Private Placement Offering
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG,…
Shattuck Labs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
– Presented positive initial dose-escalation clinical data for SL-172154, including high target occupancy, dose-dependent immune…
Enochian BioSciences and Caring Cross Announce a Partnership to Potentially Increase the Effectiveness of a CAR-T Approach for HIV Cure Currently Being Studied in Humans
LOS ANGELES, March 15, 2022 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) — Enochian BioSciences, a company focused…
Cogent Biosciences Provides Corporate Updates, Fourth Quarter and Full Year 2021 Financial Results
APEX, SUMMIT and PEAK bezuclastinib clinical trials actively enrolling patients APEX initial clinical data presentation…
Krystal Biotech Announces Settlement with PeriphaGen, Inc.
PITTSBURGH, March 15, 2022 (GLOBE NEWSWIRE) — Krystal Biotech, Inc., (“Krystal”) (NASDAQ: KRYS), the leader…
Kamada Reports Fiscal Year and Fourth Quarter 2021 Financial Results; Provides Revenue and Profitability Guidance with Significant Growth Expected in 2022
Total Revenues for Fiscal Year 2021 were $103.6 Million and Fourth Quarter 2021 Revenues were…
ASLAN Pharmaceuticals Appoints Dermatology Veteran Dr Alex Kaoukhov as Chief Medical Officer
– Dermatologist with over twenty years of experience in senior biopharma roles in the US…
Todos Medical to Present at the Emerging Growth Conference
– Wednesday, March 16, 2022 at 1:30 pm – 2 pm EST – New York,…
Roche Annual General Meeting 2022
All proposals of the Board of Directors approved Christoph Franz as Chairman of the Roche…
23andMe to Present at American Association for Cancer Research (AACR) 2022 Annual Meeting
SUNNYVALE, Calif., March 15, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a…
Highlight Therapeutics to present at the American Association for Cancer Research (AACR) Annual Meeting 2022
Final results of SPOTLIGHT203 phase 2 study demonstrate new approach to second line treatment for…
MediciNova to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest
LA JOLLA, Calif., March 15, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
ORBCOMM Launches Next-Generation IoT Solution for Data-Driven Refrigerated Container Operations
Leverages enhanced functionality and analytics for real-time visibility and control of reefer containers throughout the…
Verizon Business Expands BlueJeans Telehealth for Data-Driven Virtual Care, Everywhere
What You Need to Know: Data source expansion and new data integration capabilities in BlueJeans…
Ramon.Space Announces High-Capacity Space-Resilient Storage Solution
The company’s ultra-high density storage solution is part of the Ramon.Space compute platform that will…
Progress Transforms the Creation of Multi-Channel Digital Experiences with .NET 6
Latest release of Progress Sitefinity DX adds a new layer of composability, empowering organizations to…